Ovoca Bio (OVB) Competitors

Aptamer Group (LON:APTA) and Ovoca Bio (LON:OVB) are both small-cap medical companies, but which is the superior business? We will contrast the two companies based on the strength of their risk, valuation, institutional ownership, earnings, community ranking, media sentiment, dividends, profitability and analyst recommendations.

Which has more volatility and risk, APTA or OVB?

Aptamer Group has a beta of -0.52, indicating that its share price is 152% less volatile than the S&P 500. Comparatively, Ovoca Bio has a beta of 0.9, indicating that its share price is 10% less volatile than the S&P 500.

Which has preferable earnings and valuation, APTA or OVB?

Ovoca Bio has lower revenue, but higher earnings than Aptamer Group. Ovoca Bio is trading at a lower price-to-earnings ratio than Aptamer Group, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Aptamer Group	£4.12M	1.21	-£14.17M	-£0.71	-0.35
Ovoca Bio	N/A	N/A	-£1.35M	-£1.09	-1.28

Does the media favor APTA or OVB?

In the previous week, Aptamer Group's average media sentiment score of 0.00 equaled Ovoca Bio'saverage media sentiment score.

Company	Overall Sentiment
Aptamer Group	Neutral
Ovoca Bio	Neutral

Does the MarketBeat Community believe in APTA or OVB?

Ovoca Bio received 17 more outperform votes than Aptamer Group when rated by MarketBeat users.

Company	Underperform	Outperform
Aptamer Group	N/A	N/A
Ovoca Bio	Outperform Votes 17 70.83%	Underperform Votes 7 29.17%

Do institutionals & insiders have more ownership in APTA or OVB?

11.7% of Aptamer Group shares are held by institutional investors. 13.2% of Aptamer Group shares are held by insiders. Comparatively, 44.7% of Ovoca Bio shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock will outperform the market over the long term.

Is APTA or OVB more profitable?

Ovoca Bio has a net margin of 0.00% compared to Aptamer Group's net margin of -343.95%. Ovoca Bio's return on equity of -52.49% beat Aptamer Group's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Aptamer Group	-343.95%	-205.63%	-44.96%
Ovoca Bio	N/A	-52.49%	3.70%

Summary

Ovoca Bio beats Aptamer Group on 7 of the 11 factors compared between the two stocks.